Skip to main content
Clinical Trials/NCT03200470
NCT03200470
Unknown
Not Applicable

The Utility of Next-generation Sequencing for the Diagnosis of Periprosthetic Joint Infection

Rothman Institute Orthopaedics1 site in 1 country120 target enrollmentFebruary 16, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prosthetic Joint Infection
Sponsor
Rothman Institute Orthopaedics
Enrollment
120
Locations
1
Primary Endpoint
NextGeneration Sequencing analysis concordance with Muskuloskeletal Infection Society (MSIS) criteria for defining infection
Last Updated
8 years ago

Overview

Brief Summary

This is a prospective multicenter study. All patients presenting for revision hip or knee arthroplasty for all indications under the respective surgeon's care may be eligible. Per standard of care preoperatively, all patients must have blood drawn for erythrocyte sedimentation rate(ESR), C-reactive protein(CRP) and D-dimer. Aspiration of the joint in question may be performed at the discretion of the treating surgeon and results documented. Intraoperative samples will also be collected and sent for NGS analysis

Detailed Description

Pre-operative D-dimer testing should be performed if this is in keeping with the local institutional standard of care. Otherwise, D-dimer testing will be omitted from the pre-operative panel of tests collected. NGS results will be made available to the Investigator. Treatment will remain within keeping with the Investigator's standard of care. NGS results may be used at the discretion of the treating surgeon in guiding patient treatment.

Registry
clinicaltrials.gov
Start Date
February 16, 2017
End Date
March 2018
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing primary total hip or knee arthroplasty with no history of prior surgery
  • Patients undergoing revision hip or knee arthroplasty for septic or aseptic indication.

Exclusion Criteria

  • Patients undergoing second stage re-implantation surgery for PJI.

Outcomes

Primary Outcomes

NextGeneration Sequencing analysis concordance with Muskuloskeletal Infection Society (MSIS) criteria for defining infection

Time Frame: Immediate post-operative period (usually within 5 days following surgery)

MSIS criteria incorporates pre-operative laboratory values with tissue and fluid samples collected during surgery in an attempt to diagnose infection

Study Sites (1)

Loading locations...

Similar Trials